-
1
-
-
0016791386
-
Mathematic models for cancer chemotherapy: Pharmacokinetic and cell kinetic considerations
-
S. Chuang, "Mathematic models for cancer chemotherapy: pharmacokinetic and cell kinetic considerations," Cancer Chemother. Rep., vol. 59, no. 4, pp. 827-12, 1975.
-
(1975)
Cancer Chemother. Rep.
, vol.59
, Issue.4
, pp. 827-912
-
-
Chuang, S.1
-
2
-
-
0018939256
-
Heuristic modeling of drug delivery to malignant brain tumors
-
V. A. Levin, C. S. Patlak, and H. D. Landahl, "Heuristic modeling of drug delivery to malignant brain tumors," J. Pharmacokinet. Biopharm., pp. 257-2968, 1980.
-
(1980)
J. Pharmacokinet. Biopharm.
, pp. 257-2968
-
-
Levin, V.A.1
Patlak, C.S.2
Landahl, H.D.3
-
3
-
-
0024327711
-
Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and chinese hamster cells
-
S. Ozawa, Y. Sugiyama, J. Mitsuhashi, and M. Inaba, "Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and chinese hamster cells," Cancer Res., vol. 49, pp. 3823-3828, 1989.
-
(1989)
Cancer Res.
, vol.49
, pp. 3823-3828
-
-
Ozawa, S.1
Sugiyama, Y.2
Mitsuhashi, J.3
Inaba, M.4
-
4
-
-
0028483129
-
Teaching cancer chemotherapy by means of a computer simulation
-
Y. Jean, J. De Traversay, and P. Lemieux, "Teaching cancer chemotherapy by means of a computer simulation," Int. J. Biomed. Comput., vol. 36, pp. 273-280, 1994.
-
(1994)
Int. J. Biomed. Comput.
, vol.36
, pp. 273-280
-
-
Jean, Y.1
De Traversay, J.2
Lemieux, P.3
-
5
-
-
0344178181
-
Modelling and simulation of chemotherapy of haematological and gynaecological cancers
-
F. K. Nani and M. N. Oguztereli, "Modelling and simulation of chemotherapy of haematological and gynaecological cancers," IMA J. Math. Appl. Med. Biol., vol. 16, pp. 39-91, 1999.
-
(1999)
IMA J. Math. Appl. Med. Biol.
, vol.16
, pp. 39-91
-
-
Nani, F.K.1
Oguztereli, M.N.2
-
6
-
-
0033933808
-
Optimizing drug resistance in cancer chemotherapy by an efficacy-toxicity mathematical model
-
A. Iliadis and D. Barbolosi, "Optimizing drug resistance in cancer chemotherapy by an efficacy-toxicity mathematical model," Comput. Biomed. Res,., vol. 33, pp. 211-226, 2000.
-
(2000)
Comput. Biomed. Res.
, vol.33
, pp. 211-226
-
-
Iliadis, A.1
Barbolosi, D.2
-
7
-
-
0035125321
-
Optimizing drug regimens in cancer chemotherapy: A simulation study using a PK-PD model
-
D. Barbolosi and A. Iliadis, "Optimizing drug regimens in cancer chemotherapy: A simulation study using a PK-PD model," Comput. Biol. Med.,, vol. 31, pp. 157-172, 2001.
-
(2001)
Comput. Biol. Med.
, vol.31
, pp. 157-172
-
-
Barbolosi, D.1
Iliadis, A.2
-
8
-
-
0034309182
-
Repopulation of tumour cells between cycles of chemotherapy: A neglected factor
-
J. Davis and I. F. Tannock, "Repopulation of tumour cells between cycles of chemotherapy: A neglected factor," The Lancet Oncol., vol. 1, pp. 86-93, 2000.
-
(2000)
The Lancet Oncol.
, vol.1
, pp. 86-93
-
-
Davis, J.1
Tannock, I.F.2
-
9
-
-
0036350193
-
Modeling multi-drug chemotherapy: Tailoring treatment to individuals
-
S. N. Gardner, "Modeling multi-drug chemotherapy: Tailoring treatment to individuals," J. Theor. Biol., vol. 214, pp. 181-207, 2002.
-
(2002)
J. Theor. Biol.
, vol.214
, pp. 181-207
-
-
Gardner, S.N.1
-
10
-
-
0037299744
-
Mathematical modeling of drug transport in tumour multicell spheroids and monolayer cultures
-
J. P. Ward and J. R. King, "Mathematical modeling of drug transport in tumour multicell spheroids and monolayer cultures," Mater. Biosci., vol. 181, pp. 177-207, 2003.
-
(2003)
Mater. Biosci.
, vol.181
, pp. 177-207
-
-
Ward, J.P.1
King, J.R.2
-
11
-
-
0035145085
-
Tracking tumor growth rates in patiens with malignant gliomas: A test of two algorithm
-
S.M. Haney, P.M. Thompson, T.F. Cloughesy, J.R. Alger, and A.W. Toga, "Tracking tumor growth rates in patiens with malignant gliomas: A test of two algorithm," Amr J. Neuroradiol., vol. 22, no. 1, pp. 73-82, 2001.
-
(2001)
Amr J. Neuroradiol.
, vol.22
, Issue.1
, pp. 73-82
-
-
Haney, S.M.1
Thompson, P.M.2
Cloughesy, T.F.3
Alger, J.R.4
Toga, A.W.5
-
12
-
-
0347252327
-
Automatic brain segmentation by subject specific modification of atlas priors
-
M. Prastawa, E. Bullitt, N. Moon, K. Leemput, and G. Gerig, "Automatic brain segmentation by subject specific modification of atlas priors," Acad. Radiol., vol. 10, no. 12, pp. 1341-8, 2003.
-
(2003)
Acad. Radiol.
, vol.10
, Issue.12
, pp. 1341-1348
-
-
Prastawa, M.1
Bullitt, E.2
Moon, N.3
Leemput, K.4
Gerig, G.5
-
13
-
-
0034696767
-
Simulated brain tumor growth dynamicsusing a three-dimensional cellular automaton
-
A. Kansal, S. Torquato, G. Harsh, E. Chiocca, and T. Deisboeck, "Simulated brain tumor growth dynamicsusing a three-dimensional cellular automaton," J. Theor. Biol., vol. 203, pp. 367-382, 2000.
-
(2000)
J. Theor. Biol.
, vol.203
, pp. 367-382
-
-
Kansal, A.1
Torquato, S.2
Harsh, G.3
Chiocca, E.4
Deisboeck, T.5
-
14
-
-
0242607878
-
Virtual and real brain tumors: Using mathematical modeling to quantify glioma growth and invasion
-
K. R. Swanson, C. Bridge, J. D. Murray, and E. C. Alvord, Jr, "Virtual and real brain tumors: Using mathematical modeling to quantify glioma growth and invasion," J. Neurol. Sci., vol. 216, pp. 1-10, 2003.
-
(2003)
J. Neurol. Sci.
, vol.216
, pp. 1-10
-
-
Swanson, K.R.1
Bridge, C.2
Murray, J.D.3
Alvord Jr., E.C.4
-
15
-
-
1042291055
-
Dynamics of a model for brain tumors reveals a small window for the therapeutic intervention
-
K. Swanson, E. C. Alvord, Jr., and J. D. Murray, "Dynamics of a model for brain tumors reveals a small window for the therapeutic intervention," Discrete Continuous Dynamical Syst.-Ser. B, vol. 4, no. 1, pp. 289-295, 2004.
-
(2004)
Discrete Continuous Dynamical Syst.-Ser. B
, vol.4
, Issue.1
, pp. 289-295
-
-
Swanson, K.1
Alvord Jr., E.C.2
Murray, J.D.3
-
16
-
-
0003422388
-
-
New York: Scientific American Books
-
Lodish D. Baltimore, A. Berk, S. Zipursky, P. Matsudaira, and J. Darnell, Molecular Cell Biology. New York: Scientific American Books, 1995, pp. 1247-1294.
-
(1995)
Molecular Cell Biology
, pp. 1247-1294
-
-
Baltimore, L.D.1
Berk, A.2
Zipursky, S.3
Matsudaira, P.4
Darnell, J.5
-
17
-
-
0003539105
-
-
Perez and L. Brady, Eds., Philadelphia, PA: Lippincott-Raven
-
Perez and L. Brady, Eds., Principles and Practice of Radiation Oncology. Philadelphia, PA: Lippincott-Raven, 1998.
-
(1998)
Principles and Practice of Radiation Oncology
-
-
-
18
-
-
1542287820
-
In silico radiation oncology: Combining novel simulation algorithms with current visualization techniques
-
S. Stamatakos, D. D. Dionysiou, E. I. Zacharaki, N. A. Mouravliansky, K. S. Nikita, and N. K. Uzunoglu, "In silico radiation oncology: Combining novel simulation algorithms with current visualization techniques," Proc. IEEE, vol. 90, no. 1, pp. 1764-1777, 2002.
-
(2002)
Proc. IEEE
, vol.90
, Issue.1
, pp. 1764-1777
-
-
Stamatakos, S.1
Dionysiou, D.D.2
Zacharaki, E.I.3
Mouravliansky, N.A.4
Nikita, K.S.5
Uzunoglu, N.K.6
-
19
-
-
0029134923
-
Modeling of radiogenic responses induced by fractionated irradiation in malignant and normal tissue
-
W. Duechting, T. Ginsberg, and W. Ulmer, "Modeling of radiogenic responses induced by fractionated irradiation in malignant and normal tissue," Stem Cells, vol. 13, no. 1, pp. 301-306, 1995.
-
(1995)
Stem Cells
, vol.13
, Issue.1
, pp. 301-306
-
-
Duechting, W.1
Ginsberg, T.2
Ulmer, W.3
-
20
-
-
33746591944
-
-
G. Steel, Ed., London, U.K.: Arnold
-
G. Steel, Ed., Basic Clinical Radiobiology, 3rd ed. London, U.K.: Arnold, 2002, pp. 165-168, pp. 13, 52-63.
-
(2002)
Basic Clinical Radiobiology, 3rd Ed.
, pp. 165-168
-
-
-
21
-
-
13244297069
-
A mathematical model of doxorubicin treatment efficacy for non-Hodgkin's lymphoma: Investigation of the current protocol through theoretical modeling results
-
B. Ribba, K. Marron, Z. Agur, T. Alarcon, and P. K. Maini, "A mathematical model of doxorubicin treatment efficacy for non-Hodgkin's lymphoma: Investigation of the current protocol through theoretical modeling results," Bull. Math. Biol., vol. 67, pp. 79-99, 2005.
-
(2005)
Bull. Math. Biol.
, vol.67
, pp. 79-99
-
-
Ribba, B.1
Marron, K.2
Agur, Z.3
Alarcon, T.4
Maini, P.K.5
-
22
-
-
0034648765
-
Angiogenesis in cancer and other diseases
-
P. Carmeliet and R. K. Jain, "Angiogenesis in cancer and other diseases," Nature, vol. 407, pp. 249-259, 2002.
-
(2002)
Nature
, vol.407
, pp. 249-259
-
-
Carmeliet, P.1
Jain, R.K.2
-
23
-
-
0034660890
-
Fractals and cancer
-
W. Baish and R. F. Jain, "Fractals and cancer," Cancer Res., vol. 60, pp. 3683-3688, 2000.
-
(2000)
Cancer Res.
, vol.60
, pp. 3683-3688
-
-
Baish, W.1
Jain, R.F.2
-
24
-
-
0030614893
-
Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
-
G. Helmlinger, F. Yuan, M. Dellian, and R. K. Jain, "Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation," Nature Med., vol. 3, pp. 177-182, 1997.
-
(1997)
Nature Med.
, vol.3
, pp. 177-182
-
-
Helmlinger, G.1
Yuan, F.2
Dellian, M.3
Jain, R.K.4
-
25
-
-
0032516078
-
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
-
S. K. Hobbs, W. L. Monsky, F. Yuan, W. G. Roberts, L. Griffith, V. P. Torchilin, and R. K. Jain, "Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment," Proc. Nat. Acad. Sci., USA, vol. 95, pp. 4607-4612, 1998.
-
(1998)
Proc. Nat. Acad. Sci., USA
, vol.95
, pp. 4607-4612
-
-
Hobbs, S.K.1
Monsky, W.L.2
Yuan, F.3
Roberts, W.G.4
Griffith, L.5
Torchilin, V.P.6
Jain, R.K.7
-
26
-
-
0033839080
-
Openings between defective endothelial cells explain tumor vessel leakiness
-
H. Hashizume, P. Baluk, S. Morikawa, J. W. McLean, G. Thurston, S. Roberge, R. K. Jain, and D. M. McDonald, "Openings between defective endothelial cells explain tumor vessel leakiness," Am. J. Pathol., vol. 156, pp. 1363-1380, 2000.
-
(2000)
Am. J. Pathol.
, vol.156
, pp. 1363-1380
-
-
Hashizume, H.1
Baluk, P.2
Morikawa, S.3
McLean, J.W.4
Thurston, G.5
Roberge, S.6
Jain, R.K.7
McDonald, D.M.8
-
27
-
-
0031105962
-
Positive feedback and angiogenesis in tumor growth control
-
Michelson and J. T. Leith, "Positive feedback and angiogenesis in tumor growth control," Bull. Math. Biol,., vol. 59, no. 2, pp. 233-254, 1997.
-
(1997)
Bull. Math. Biol,.
, vol.59
, Issue.2
, pp. 233-254
-
-
Michelson1
Leith, J.T.2
-
28
-
-
0034005995
-
Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma
-
S. Agarwala and J. Kirkwood, "Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma," The Oncologist, vol. 5, pp. 144-151, 2000.
-
(2000)
The Oncologist
, vol.5
, pp. 144-151
-
-
Agarwala, S.1
Kirkwood, J.2
-
29
-
-
0030993717
-
Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials
-
E. S. Newlands, M. F. Stevens, S. R. Wedge, R. T. Wheelhouse, and C. Brock, "Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials," Cancer Treat. Rev., vol. 23, pp. 35-61, 1997.
-
(1997)
Cancer Treat. Rev.
, vol.23
, pp. 35-61
-
-
Newlands, E.S.1
Stevens, M.F.2
Wedge, S.R.3
Wheelhouse, R.T.4
Brock, C.5
-
30
-
-
0037818564
-
A review of its use in the treatment of malignant gliomas, malignant melanoma and other advanced cancers
-
M. J.M. Darkes, G. L. Plosker, B. Jarvis, and Temozolomide, "A review of its use in the treatment of malignant gliomas, malignant melanoma and other advanced cancers," Am. J. Cancer, vol. 1, no. 1, pp. 55-80, 2002.
-
(2002)
Am. J. Cancer
, vol.1
, Issue.1
, pp. 55-80
-
-
Darkes, M.J.M.1
Plosker, G.L.2
Jarvis, B.3
Temozolomide4
-
31
-
-
0004246255
-
-
Menlo Park, CA: Benjamin/Cummings
-
Watson, N. Hopkins, J. Roberts, J. Steitz, and A. Weiner, Molecular Biology of the Gene, 4th ed. Menlo Park, CA: Benjamin/Cummings, 1987, pp. 1006-1096.
-
(1987)
Molecular Biology of the Gene, 4th Ed.
, pp. 1006-1096
-
-
Watson1
Hopkins, N.2
Roberts, J.3
Steitz, J.4
Weiner, A.5
-
32
-
-
0007047636
-
Algorithmic description of the biological activity of a solid tumor in vivo
-
Delft, The Netherlands, Jun. 26-29, CD-ROM
-
G. Stamatakos, D. Dionysiou, N. Mouravliansky, K. Nikita, G. Pissakas, P. Georgolopoulou, and N. Uuznoglu, "Algorithmic description of the biological activity of a solid tumor in vivo," in Proc. EUROSIM 2001 Congress, Delft, The Netherlands, Jun. 26-29, 2001, (CD-ROM).
-
(2001)
Proc. EUROSIM 2001 Congress
-
-
Stamatakos, G.1
Dionysiou, D.2
Mouravliansky, N.3
Nikita, K.4
Pissakas, G.5
Georgolopoulou, P.6
Uuznoglu, N.7
-
33
-
-
2342641211
-
Tumor growth and response to irradiation in vitro: A technologically advanced simulation model
-
G. Stamatakos, E. I. Zacharaki, N. K. Uzunoglu, and K. S. Nikita, "Tumor growth and response to irradiation in vitro: A technologically advanced simulation model," in Int. J. Radiat. Oncol. Biol. Phys., 2001, vol. 51, no. 1, pp. 240-241.
-
(2001)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.51
, Issue.1
, pp. 240-241
-
-
Stamatakos, G.1
Zacharaki, E.I.2
Uzunoglu, N.K.3
Nikita, K.S.4
-
34
-
-
0033638464
-
Population pharmacokinetics of temozolomide in cancer patients
-
J. F. Jen, D. L. Cutler, S. M. Pai, V. K. Batra, M. B. Affrime, D. N. Zambas, S. Heft, and G. Hajian, "Population pharmacokinetics of temozolomide in cancer patients," Pharm. Res., vol. 17, no. 9, pp. 1284-1289, 2000.
-
(2000)
Pharm. Res.
, vol.17
, Issue.9
, pp. 1284-1289
-
-
Jen, J.F.1
Cutler, D.L.2
Pai, S.M.3
Batra, V.K.4
Affrime, M.B.5
Zambas, D.N.6
Heft, S.7
Hajian, G.8
-
35
-
-
3242691996
-
-
Hamilton, ON, Canada: BC Decker
-
R. C. Bast, D. W. Kufe, R. E. Pollock, R. R. Weichselbaum, J. F. Holland, and E. Frei, Holland-Frei Cancer Medicine, 6th ed. Hamilton, ON, Canada: BC Decker, 2000.
-
(2000)
Holland-Frei Cancer Medicine, 6th Ed.
-
-
Bast, R.C.1
Kufe, D.W.2
Pollock, R.E.3
Weichselbaum, R.R.4
Holland, J.F.5
Frei, E.6
-
37
-
-
0003499531
-
-
M. C. Perry, Ed., Philadelphia, PA: Lippincott Williams and Wilkins
-
M. C. Perry, Ed., The Chemotherapy Source Book, 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2001.
-
(2001)
The Chemotherapy Source Book, 3rd Ed.
-
-
-
38
-
-
33746593974
-
-
Revision date: 2/2/1999, Application Number: 21029
-
"FDA, Center for Drug Evaluation and Research," Drug Name: Temozolomide (Temodal), New Drug Application, Clinical Pharmacology and Biopharmaceutics Reviews pp. 19-20, Revision date: 2/2/1999, Application Number: 21029.
-
Drug Name: Temozolomide (Temodal), New Drug Application, Clinical Pharmacology and Biopharmaceutics Reviews
, pp. 19-20
-
-
-
40
-
-
0036536697
-
Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance
-
J. Ma, M. Murphy, P. J. O'Dwyer, E. Berman, K. Reed, and J. M. Gallo, "Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance," Biochem. Pharmacol., vol. 63, pp. 1219-1228, 2002.
-
(2002)
Biochem. Pharmacol.
, vol.63
, pp. 1219-1228
-
-
Ma, J.1
Murphy, M.2
O'Dwyer, P.J.3
Berman, E.4
Reed, K.5
Gallo, J.M.6
-
41
-
-
0037217219
-
Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: A phase I dose-escalation study
-
S. S. Agarwala and J. M. Kirkwood, "Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: A phase I dose-escalation study," Cancer, vol. 97, pp. 121-127, 2003.
-
(2003)
Cancer
, vol.97
, pp. 121-127
-
-
Agarwala, S.S.1
Kirkwood, J.M.2
-
42
-
-
0037428798
-
Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids
-
W. Günther, E. Pawlak, R. Damasceno, H. Arnold, and A. J. Terzis, "Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids," Br. J. Cancer,., vol. 88, pp. 463-469, 2003.
-
(2003)
Br. J. Cancer
, vol.88
, pp. 463-469
-
-
Günther, W.1
Pawlak, E.2
Damasceno, R.3
Arnold, H.4
Terzis, A.J.5
-
43
-
-
0027007689
-
O6-alkylguanine DNA-alkyltransferase is not a major determinant of sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea in four medulloblastoma cell lines
-
J. R. Silber, M. S. Bobola, T. G. Ewers, M. Muramoto, and M. S. Berger, "O6-alkylguanine DNA-alkyltransferase is not a major determinant of sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea in four medulloblastoma cell lines," Oncol. Res., vol. 4, pp. 241-248, 1992.
-
(1992)
Oncol. Res.
, vol.4
, pp. 241-248
-
-
Silber, J.R.1
Bobola, M.S.2
Ewers, T.G.3
Muramoto, M.4
Berger, M.S.5
-
44
-
-
0003257713
-
A phase i study of SCH52365 (Temozolomide) in adult patients with advanced cancer
-
M. Brada, "A phase i study of SCH52365 (Temozolomide) in adult patients with advanced cancer," in Proc. Am. Soc. Clinical Oncology, 1995, vol. 14, no. 470.
-
(1995)
Proc. Am. Soc. Clinical Oncology
, vol.14
, Issue.470
-
-
Brada, M.1
-
45
-
-
0026513077
-
Phase I Trial of Temozolomide CCRG 81045: M&B 39831:NSC 362856
-
E. S. Newlands, "Phase I Trial of Temozolomide (CCRG 81045: M&B 39831:NSC 362856," Br. J. Cancer, vol. 65, pp. 287-291, 1992.
-
(1992)
Br. J. Cancer
, vol.65
, pp. 287-291
-
-
Newlands, E.S.1
-
46
-
-
0003626981
-
Promising survival with concomitant and adjuvant temozolomide for newly diagnosed glioblastoma multiform
-
New Orleans, LA, May Abstract ASCO, 36th Ann. Mtg.
-
R. Stupp, "Promising survival with concomitant and adjuvant temozolomide for newly diagnosed glioblastoma multiform," in Proc. A. Soc. Clin. Oncol. New Orleans, LA, May 2000, 19, Abstract (632), 20-23, ASCO, 36th Ann. Mtg..
-
(2000)
Proc. A. Soc. Clin. Oncol.
, vol.19
, Issue.632
, pp. 20-23
-
-
Stupp, R.1
-
47
-
-
0035469483
-
Current and future developments in the use of temozolomide for the treatment of brain tumours
-
R. Stupp, M. Gander, S. Leyvraz, and E. Newlands, "Current and future developments in the use of temozolomide for the treatment of brain tumours," Lancet Oncol. Rev., vol. 2, no. 9, pp. 552-560, 2001.
-
(2001)
Lancet Oncol. Rev.
, vol.2
, Issue.9
, pp. 552-560
-
-
Stupp, R.1
Gander, M.2
Leyvraz, S.3
Newlands, E.4
-
48
-
-
33746612234
-
Mathematical Methods in Pharmacokinetics. I Use of the Laplace Transform for Solving Differential Rate Equations
-
M. Mayersohn and M. Gibaldi, "Mathematical Methods in Pharmacokinetics. I Use of the Laplace Transform for Solving Differential Rate Equations," Am. J. Pharm., Education, vol. 34, pp. 608-614, 1970.
-
(1970)
Am. J. Pharm., Education
, vol.34
, pp. 608-614
-
-
Mayersohn, M.1
Gibaldi, M.2
-
49
-
-
12944253684
-
Mathematical Methods in Pharmacokinetics II Solution of the Two Compartment Open Model
-
M. Mayersohn and M. Gibaldi, Amer. J. Pharm., Ed.
-
M. Mayersohn and M. Gibaldi, Amer. J. Pharm., Ed., "Mathematical Methods in Pharmacokinetics II Solution of the Two Compartment Open Model," Am. J. Pharm. Educ., vol. 35, pp. 19-28, 1971.
-
(1971)
Am. J. Pharm. Educ.
, vol.35
, pp. 19-28
-
-
-
50
-
-
0015318113
-
General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics
-
L. Z. Benet, "General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics," J. Pharm. Sci., vol. 61, pp. 536-541, 1972.
-
(1972)
J. Pharm. Sci.
, vol.61
, pp. 536-541
-
-
Benet, L.Z.1
-
51
-
-
0035340512
-
Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy
-
O.L. Chinot, S. Honore, H. Dufour, M. Barrie, D. Figarella-Branger, X. Muracciole, D. Braguer, P. M. Martin, and F. Grisoli, "Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy," J. Clin. Oncol., vol. 19, no. 2, pp. 449-55, 2001.
-
(2001)
J. Clin. Oncol.
, vol.19
, Issue.2
, pp. 449-455
-
-
Chinot, O.L.1
Honore, S.2
Dufour, H.3
Barrie, M.4
Figarella-Branger, D.5
Muracciole, X.6
Braguer, D.7
Martin, P.M.8
Grisoli, F.9
-
52
-
-
0037010054
-
The treatment of brain metastases from malignant melanoma
-
J. G. Douglas and K. Margolin, "The treatment of brain metastases from malignant melanoma," Semin. Oncol., vol. 29, pp. 518-524, 2002.
-
(2002)
Semin. Oncol.
, vol.29
, pp. 518-524
-
-
Douglas, J.G.1
Margolin, K.2
-
53
-
-
0344211864
-
Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer
-
B. L. Ebert, E. Niemierko, K. Shaffer, and R. Salgia, "Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer," Oncologist, vol. 8, pp. 69-75, 2003.
-
(2003)
Oncologist
, vol.8
, pp. 69-75
-
-
Ebert, B.L.1
Niemierko, E.2
Shaffer, K.3
Salgia, R.4
-
54
-
-
0017342804
-
Current status of population kinetics in gliomas
-
D. C. Crafts, T. Hoshino T, and Wilson CB, "Current status of population kinetics in gliomas," Bull. Cancer, vol. 64, pp. 115-124, 1977.
-
(1977)
Bull. Cancer
, vol.64
, pp. 115-124
-
-
Crafts, D.C.1
Hoshino T, T.2
Wilson, C.B.3
-
55
-
-
0020962536
-
Spiromustine: A new agent entering clinical trials
-
D. D. Shoemaker, P. J. O'Dwyer, S. Marsoni, J. Plowman, J. P. Davignon, and R. D. Davis, "Spiromustine: A new agent entering clinical trials," Invest New Drugs, vol. 1, pp. 303-308, 1983.
-
(1983)
Invest New Drugs
, vol.1
, pp. 303-308
-
-
Shoemaker, D.D.1
O'Dwyer, P.J.2
Marsoni, S.3
Plowman, J.4
Davignon, J.P.5
Davis, R.D.6
-
56
-
-
0015071439
-
Pharmacodynamics of chemotherapeutic effects: Dose-time-response relationships for phase-nonspecific agents
-
W. J. Jusko, "Pharmacodynamics of chemotherapeutic effects: Dose-time-response relationships for phase-nonspecific agents," J. Pharm. Sci., vol. 60, no. 6, pp. 892-895, 1971.
-
(1971)
J. Pharm. Sci.
, vol.60
, Issue.6
, pp. 892-895
-
-
Jusko, W.J.1
-
57
-
-
0014889972
-
Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules
-
H. E. Skipper, F. M. Schabel, L. B. Mellett, J. A. Montgomery, L. J. Wilkoff, H. H. Lloyd, and R. W. Brockman, "Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules," Cancer Chemother., vol. 54, pp. 431-450, 1970.
-
(1970)
Cancer Chemother.
, vol.54
, pp. 431-450
-
-
Skipper, H.E.1
Schabel, F.M.2
Mellett, L.B.3
Montgomery, J.A.4
Wilkoff, L.J.5
Lloyd, H.H.6
Brockman, R.W.7
-
58
-
-
0018957289
-
Dependence of the cytostatic effect of adriamycin on drug concenration and exposure time in vitro
-
H. Eichholtz-Wirth, "Dependence of the cytostatic effect of adriamycin on drug concenration and exposure time in vitro," Br. J. Cancer, vol. 41, pp. 886-891, 1980.
-
(1980)
Br. J. Cancer
, vol.41
, pp. 886-891
-
-
Eichholtz-Wirth, H.1
-
59
-
-
0029657595
-
Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin
-
M. S. Bobola, S. H. Tseng, A. Blank, M. S. Berger, and J. R. Silber, "Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin," Clin. Cancer Res., vol. 2, pp. 735-741, 1996.
-
(1996)
Clin. Cancer Res.
, vol.2
, pp. 735-741
-
-
Bobola, M.S.1
Tseng, S.H.2
Blank, A.3
Berger, M.S.4
Silber, J.R.5
-
60
-
-
0028980765
-
Contribution of O6-methylguanine-DNA methyltransferase to resistance to 1,3-(2-chloroethyl)-1-nitrosourea in human brain tumor-derived cell lines
-
M. S. Bobola, M. S. Berger, and J. R. Silber, "Contribution of O6-methylguanine-DNA methyltransferase to resistance to 1,3-(2-chloroethyl)-1- nitrosourea in human brain tumor-derived cell lines," Mol. Carcinog., vol. 13, pp. 81-88, 1995.
-
(1995)
Mol. Carcinog.
, vol.13
, pp. 81-88
-
-
Bobola, M.S.1
Berger, M.S.2
Silber, J.R.3
-
61
-
-
2342512813
-
A spatiotemporal simulation model of the response of solid tumors to radiotherapy in vivo: Parametric validation concerning oxygen enhancement ratio and cell cycle duration
-
V. Antipas, G. S. Stamatakos, N. Uzunoglu, D. Dionysiou, and R. Dale, "A spatiotemporal simulation model of the response of solid tumors to radiotherapy in vivo: Parametric validation concerning oxygen enhancement ratio and cell cycle duration," Phys. Med. Biol., vol. 49, pp. 1-20, 2004.
-
(2004)
Phys. Med. Biol.
, vol.49
, pp. 1-20
-
-
Antipas, V.1
Stamatakos, G.S.2
Uzunoglu, N.3
Dionysiou, D.4
Dale, R.5
-
62
-
-
0034851923
-
Tumor control probability modelling: Basic principles and applications in treatment planning
-
Nahum and B. Sanchez-Nieto, "Tumor control probability modelling: Basic principles and applications in treatment planning," Physica Medica, vol. 17, no. 2, pp. 13-23, 2001.
-
(2001)
Physica Medica
, vol.17
, Issue.2
, pp. 13-23
-
-
Nahum1
Sanchez-Nieto, B.2
-
63
-
-
0026703552
-
Computer simulation and modeling of tumor spheroid growth and their relevance for optimization of fractionated radiotherapy
-
W. Duechting, W. Ulmer, R. Lehrig, T. Ginsberg, and E. Dedeleit, "Computer simulation and modeling of tumor spheroid growth and their relevance for optimization of fractionated radiotherapy," Strahlenther. Onkol., vol. 168, no. 6, pp. 354-360, 1992.
-
(1992)
Strahlenther. Onkol.
, vol.168
, Issue.6
, pp. 354-360
-
-
Duechting, W.1
Ulmer, W.2
Lehrig, R.3
Ginsberg, T.4
Dedeleit, E.5
-
64
-
-
0034309182
-
Repopulation of tumour cells between cycles of chemotherapy: A neglected factor
-
A. J. Davis and I. F. Tannock, "Repopulation of tumour cells between cycles of chemotherapy: A neglected factor," Lancet Oncol., vol. 1, pp. 86-93, 2000.
-
(2000)
Lancet Oncol.
, vol.1
, pp. 86-93
-
-
Davis, A.J.1
Tannock, I.F.2
-
65
-
-
0022205483
-
Stem cell studies of human malignant brain tumours Part 2: Proliferation kinetics of brain-tumour cells in vitro in early-passage cultures
-
B. Pertuiset B. D. Dougherty, C. Cromeyer, T. Hoshino, M. Berger, and M.L.J. Rosenblum, "Stem cell studies of human malignant brain tumours Part 2: Proliferation kinetics of brain-tumour cells in vitro in early-passage cultures," Neurosurgery, vol. 63, no. 3, pp. 426-32, 1985.
-
(1985)
Neurosurgery
, vol.63
, Issue.3
, pp. 426-432
-
-
Pertuiset, B.1
Dougherty, B.D.2
Cromeyer, C.3
Hoshino, T.4
Berger, M.5
Rosenblum, M.L.J.6
-
66
-
-
3242707711
-
A Four dimensional in vivo model of tumour response to radiotherapy: Parametric validation considering radiosensitivity, genetic profile and fractionation
-
D.D. Dionysiou, G.S. Stamatakos, N.K. Uzunoglu, K.S. Nikita, and A. Marioli, "A Four dimensional in vivo model of tumour response to radiotherapy: Parametric validation considering radiosensitivity, genetic profile and fractionation," J. Theor. Biol., vol. 230, pp. 1-20, 2004.
-
(2004)
J. Theor. Biol.
, vol.230
, pp. 1-20
-
-
Dionysiou, D.D.1
Stamatakos, G.S.2
Uzunoglu, N.K.3
Nikita, K.S.4
Marioli, A.5
|